TIMBER PHARMACEUTICALS
Timber Pharmaceuticals is a privately held biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases.
TIMBER PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2019-01-01
Address:
Woodcliff Lake, New Jersey, United States
Country:
United States
Website Url:
http://www.timberpharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
500 K USD
Technology used in webpage:
Euro
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
DermAvance Pharmaceuticals
DermAvance Pharmaceuticals, Inc. is a privately held dermatology pharmaceutical company.
Diartis Pharmaceuticals
Diartis Pharmaceuticals is a privately held biopharmaceutical company.
Discover Biopharmaceutical Search and Placement
Discover Biopharmaceutical Search and Placement is a boutique search firm dedicated to the biopharmaceutical field.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-01-01 | BioPharmX | BioPharmX acquired by Timber Pharmaceuticals | N/A |
Investors List
U.S. Food and Drug Administration
U.S. Food and Drug Administration investment in Grant - Timber Pharmaceuticals
Official Site Inspections
http://www.timberpharma.com Semrush global rank: 7.09 M Semrush visits lastest month: 890
Unable to get host informations!!!
More informations about "Timber Pharmaceuticals"
Timber Pharmaceuticals - Crunchbase Company Profile & Funding
Timber Pharmaceuticals is a privately held biopharmaceutical company. Timber Pharmaceuticals may be growing. The company has signed an agreement to be acquired by LEO Pharma, …See details»
Timber Pharmaceuticals | LEO Pharma
For more information, please contact [email protected]. LEO Pharma A/S. Industriparken 55 DK-2750 Ballerup Denmark. Tel. +45 4494 5888 CVR No. 56759514. FOLLOW US. X (Twitter) LinkedIn; Facebook;See details»
Timber Pharmaceuticals - PitchBook
Timber Pharmaceuticals General Information Description. Trex Wind Down Inc formerly, Timber Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the …See details»
LEO Pharma Signs Agreement to Acquire Timber Pharmaceutical
Aug 21, 2023 For more information, visit www.timberpharma.com. About LEO Pharma. LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of …See details»
Timber Pharmaceuticals, Inc., a LEO Pharma company
Timber Pharmaceuticals, Inc., a LEO Pharma company | 2,003 followers on LinkedIn. Timber Pharmaceuticals, Inc. – a LEO Pharma company, was formed in January 2024 through the …See details»
Timber Pharmaceuticals to be Acquired by LEO Pharma
Aug 21, 2023 For more information, visit www.timberpharma.com. About LEO Pharma. LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of …See details»
Timber Pharmaceuticals - Overview, News & Similar companies
Mar 10, 2024 Timber Pharmaceuticals contact info: Phone number: (908) 636-7160 Website: www.timberpharma.com What does Timber Pharmaceuticals do? Timber Pharmaceuticals, …See details»
Timber Pharmaceuticals LLC - Drug pipelines, Patents ... - Patsnap
Explore Timber Pharmaceuticals LLC with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 5 news, and 4 literature, Disease Domain:Immune System Diseases, …See details»
About TIMBER PHARMACEUTICALS, INC. | DxMultiomics
Timberpharma.com. Mark. Timber Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and …See details»
Timber Pharmaceuticals, Inc., a LEO Pharma company
Apr 6, 2020 Rare Disease Focus Timber Pharmaceuticals, specializing in rare skin diseases with limited treatment options, presents an opportunity for niche market penetration and product …See details»
Timber Pharmaceuticals to be Acquired by LEO Pharma …
Aug 21, 2023 Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to ...See details»
Timber Pharmaceuticals, Inc. - SignalHire
Organization Website: timberpharma.com : Social Links: Contact Email: [email protected]: Timber Pharmaceutica... industries Pharma: Headquarters Location: 110 Allen Road, Basking …See details»
Timber Pharmaceuticals - VentureRadar
Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»
Timber Pharmaceuticals - Craft
Jan 30, 2024 Timber Pharmaceuticals has 5 employees at their 1 location and $83.18 k in annual revenue in FY 2022. See insights on Timber Pharmaceuticals including office locations, …See details»
Timber Pharmaceuticals Announces Commencement of NYSE …
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company …See details»
Timber Pharmaceuticals Inc. - Cruelty Free Investing
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The …See details»
Timber Pharmaceuticals to be Acquired by LEO Pharma
Aug 21, 2023 [email protected]. Investor Relations: Stephanie Prince PCG Advisory (646) 863-6341 [email protected]. Media Relations: Adam Daley Berry & Company …See details»
Timber Pharmaceuticals, Inc. in Basking Ridge, NJ - (914) 205-3481
Timber Pharmaceuticals, Inc. is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to …
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage …See details»
Timber Pharmaceuticals Receives European Orphan Drug
Feb 24, 2023 [email protected]. Investor Relations: Stephanie Prince PCG Advisory (646) 863-6341 [email protected]. Media Relations: Adam Daley Berry & Company …See details»